Beyondspring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During Esmo Congress 2024 Showcasing Its Lead Anti-Cancer Asset, Plinabulin
萬春醫藥宣佈將在2024年世界肺癌大會上進行口頭報告，並在2024年ESMO大會期間展示其領先的抗癌資產Plinabulin的兩個海報報告。